IL10 and Alzheimer disease: It has also been shown that, in some instances, elevated levels of IL-10 can hinder the resolution of inflammation and drive disease progression in murine models of AD (Chakrabarty et al., 2015) thus supporting the anti-inflammatory capability of the probiotic.